TSPO expression has been suggested as a biomarker for brain disorders characterised by activated microglia, such as Alzheimer’s disease (AD), multiple sclerosis (MS), stroke and cancer (James et al. 2008). The gene discussed is TSPO; the disease is Alzheimer disease.